S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

$30.08
-0.15 (-0.50%)
(As of 04/17/2024 ET)
Today's Range
$30.08
$30.37
50-Day Range
$30.08
$35.15
52-Week Range
$30.06
$40.48
Volume
5.04 million shs
Average Volume
2.21 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.93%
Price Target
$40.00

Roche MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
33.0% Upside
$40.00 Price Target
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.33mentions of Roche in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.10%
From $2.47 to $2.67 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.47 out of 5 stars

RHHBY stock logo

About Roche Stock (OTCMKTS:RHHBY)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

RHHBY Stock Price History

RHHBY Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Guru Fundamental Report for RHHBY
Why Roche Holdings Stock Popped Today
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Roche Holding AG (RHHBY)
Roche Holding AG's Dividend Analysis
Roche Annual General Meeting 2024
See More Headlines
Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,605
Year Founded
1896

Price Target and Rating

Average Stock Price Target
$40.00
High Stock Price Target
$40.00
Low Stock Price Target
$40.00
Potential Upside/Downside
+33.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$65.37 billion
Cash Flow
$3.06 per share
Book Value
$4.91 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.39

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Severin Schwan Ph.D. (Age 57)
    Executive Chairman
    Comp: $8.31M
  • Dr. Thomas Schinecker (Age 49)
    Chief Executive Officer
    Comp: $4.28M
  • Dr. Alan Hippe (Age 57)
    Chief Financial & Information Officer
    Comp: $4.54M
  • Dr. Bruno Eschli
    Head of Investor Relations
  • Ms. Claudia Bockstiegel (Age 60)
    General Counsel
  • Ms. Pascale Schmidt (Age 51)
    Chief Compliance Officer
  • Ms. Barbara Schadler (Age 62)
    Head of Group Communications
  • Ms. Cristina A. Wilbur (Age 57)
    Chief People Officer
    Comp: $3.23M
  • Dr. Nicolas Dunant
    Head of Group Media Relations
  • Mr. Boris L. Zaitra (Age 52)
    Head of Group Business Development and M&A

RHHBY Stock Analysis - Frequently Asked Questions

Should I buy or sell Roche stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" RHHBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares.
View RHHBY analyst ratings
or view top-rated stocks.

What is Roche's stock price target for 2024?

6 analysts have issued 1 year target prices for Roche's shares. Their RHHBY share price targets range from $40.00 to $40.00. On average, they expect the company's stock price to reach $40.00 in the next twelve months. This suggests a possible upside of 33.0% from the stock's current price.
View analysts price targets for RHHBY
or view top-rated stocks among Wall Street analysts.

How have RHHBY shares performed in 2024?

Roche's stock was trading at $36.23 at the beginning of 2024. Since then, RHHBY stock has decreased by 17.0% and is now trading at $30.08.
View the best growth stocks for 2024 here
.

Is Roche a good dividend stock?

Roche (OTCMKTS:RHHBY) pays an annual dividend of $0.88 per share and currently has a dividend yield of 2.86%.
Read our dividend analysis for RHHBY.

What ETFs hold Roche's stock?
Who are Roche's major shareholders?

Roche's stock is owned by a variety of retail and institutional investors. Top institutional investors include Saratoga Research & Investment Management (0.00%), Norman Fields Gottscho Capital Management LLC (0.00%), Fulton Bank N.A. (0.00%), Confluence Investment Management LLC (0.00%) and GAMMA Investing LLC (0.00%).

How do I buy shares of Roche?

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Roche have any subsidiaries?
The following companies are subsidiares of Roche: 454 Life Sciences, Adheron Therapeutics, Adheron Therapeutics Inc., Anadys Pharmaceuticals, Anadys Pharmaceuticals Inc., Ariosa Diagnostics, Ariosa Diagnostics Inc., Arius Research, Ascur Versicherungsvermittlungs GmbH, BINA Technology, Bina Technologies Inc., BioImagene, BioVeris, BioVeris Corporation, Biopharm AG, Boehringer Mannheim, Borean Pharma, Chemical Manufacturing and Trading Company Limited, Chugai Pharmaceutical Co. Ltd., Disetronic Holding AG, Dutalys GmbH, F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche Ltd / Jordan P.S.C., FLLC "Roche Products Limited", FMI Germany GmbH, Flatiron Health, Flatiron Health Inc., ForSight Labs, ForSight VISION4 Inc., Foundation Medicine, Foundation Medicine Inc., Foundation Medicine Securities Corporation, Galenus Mannheim Pharma GmbH, GeneWEAVE, GeneWEAVE Biosciences Inc., Genentech, Genentech Inc., Genentech P.R. Inc., Genentech USA Inc., Genia Technologies, Hoffmann - La Roche Ltd, Hoffmann-La Roche Inc., Hoffmann-La Roche Limited, Hoffmann-La Roche Products Limited, I5 Surviving Corp., IGEN International Inc., IGEN LS LLC, IQuum, IQuum Inc., Ignyta, Ignyta Inc., Inflazome, Infogenetik Moleküler Bilgi Hizmetleri Anonim Sirketi, Institut Roche SAS, InterMune, InterMune Holdings Limited, InterMune Inc., InterMune International AG, Jecure Therapeutics Inc., Kapa Biosystems, Kapa Biosystems (Pty) Ltd, Kapa Biosystems Inc., Limited Liability Company Roche Diabetes Care Rus, Limited Liability Company Roche Diagnostics Rus, MTM Laboratories, Marcadia Biotech, Medingo Ltd., Medingo Medical Solutions, Memory Pharmaceuticals, Memory Pharmaceuticals Corp., Mirus, Museum Tinguely AG, N.V. Roche S.A., P.T. Roche Indonesia, PVT Probenverteiltechnik GmbH, Phaor AG, Piramed, Productos Roche (El Salvador) S.A. de C.V., Productos Roche (Honduras) S.A., Productos Roche (Nicaragua) S.A., Productos Roche (Panama) S.A., Productos Roche Dominicana S.R.L., Productos Roche Guatemala (Sociedad Anónima), Productos Roche Interamericana S.A. (PRISA), Productos Roche Química Farmacéutica S.A., Productos Roche S.A., Productos Roche S.A. Química e Industrial, Productos Roche S.A. de C.V., Produtos Roche Químicos e Farmacêuticos S.A., Promedior, Rabbit-Air Ltd, RoDiagnostics Egypt for Trading S.A.E, Roche (China) Holding Ltd., Roche (Hellas) S.A., Roche (Hungary) Ltd, Roche (Malaysia) Sdn. Bhd., Roche (Philippines) Inc., Roche (Shanghai) Pharmaceuticals Consulting Co. Ltd, Roche (Shanghai) Pharmaceuticals Trading Co. Ltd., Roche - Moscow Ltd., Roche AB, Roche Algérie SPA, Roche Austria GmbH, Roche Bangladesh Limited, Roche Beteiligungs GmbH, Roche Biomedical Laboratories Inc., Roche Bolivia SRL., Roche Bulgaria EOOD, Roche Cameroun SARL, Roche Capital Market Ltd, Roche Capital Services Ltd., Roche Catalyst Investments Ltd., Roche Chemische Unternehmungen AG, Roche Chile Limitada, Roche Côte d’Ivoire SARL, Roche DC Japan K. K., Roche DC México S.A. de C.V., Roche Deutschland Holding GmbH, Roche Diabetes Care (Switzerland) Ltd, Roche Diabetes Care Argentina S.A., Roche Diabetes Care Asia Pacific Pte. Ltd., Roche Diabetes Care Australia Pty Limited, Roche Diabetes Care Austria GmbH, Roche Diabetes Care Brasil Ltda., Roche Diabetes Care Deutschland GmbH, Roche Diabetes Care France SAS, Roche Diabetes Care GmbH, Roche Diabetes Care Inc., Roche Diabetes Care India Private Limited, Roche Diabetes Care Italy S.p.A., Roche Diabetes Care Limited, Roche Diabetes Care Middle East FZCO, Roche Diabetes Care Nederland B.V., Roche Diabetes Care Polska sp. z o.o., Roche Diabetes Care South Africa Proprietary Limited, Roche Diabetes Care Spain S.L., Roche Diagnostica Brasil Ltda., Roche Diagnostics (Hellas) S.A., Roche Diagnostics (Hong Kong) Limited, Roche Diagnostics (Malaysia) Sdn. Bhd., Roche Diagnostics (Shanghai) Ltd., Roche Diagnostics (Suzhou) Limited, Roche Diagnostics (Switzerland) Ltd, Roche Diagnostics (Thailand) Limited, Roche Diagnostics Asia Pacific Pte. Ltd., Roche Diagnostics Australia Pty. Limited, Roche Diagnostics Belgium NV, Roche Diagnostics Corporation, Roche Diagnostics Deutschland GmbH, Roche Diagnostics France SAS, Roche Diagnostics GmbH, Roche Diagnostics Hematology Inc., Roche Diagnostics India Private Limited, Roche Diagnostics International Ltd, Roche Diagnostics K.K., Roche Diagnostics Korea Co. Ltd., Roche Diagnostics Limited, Roche Diagnostics Ltd., Roche Diagnostics Middle East FZCO, Roche Diagnostics NZ Limited, Roche Diagnostics Nederland B.V., Roche Diagnostics Norge A/S, Roche Diagnostics Operations Inc., Roche Diagnostics Oy, Roche Diagnostics Polska Sp. z o.o., Roche Diagnostics Proprietary Limited, Roche Diagnostics S.L., Roche Diagnostics S.p.A., Roche Diagnostics Scandinavia AB, Roche Diagnostics Turkey Anonim Sirketi, Roche Diagnostics a/s, Roche Ecuador S.A., Roche Eesti OÜ, Roche Egypt LLC, Roche Egypt for Manufacturing and Trading SAE, Roche Farma (Peru) S.A., Roche Farma S.A., Roche Farmacêutica Química Lda., Roche Finance Europe B.V., Roche Finance Ltd, Roche Financial Investments Ltd., Roche Financial Management Ltd., Roche Financial Services Ltd., Roche Forum Buonas Ltd, Roche Georgia LLC, Roche Glycart, Roche Glycart Ltd, Roche Health Solutions Inc., Roche Holding (UK) Limited, Roche Holdings Inc., Roche Hong Kong Limited, Roche Innovation Center Copenhagen A/S, Roche Innovatis, Roche International Ltd., Roche International Ltd. (Montevideo Branch), Roche Intertrade Limited, Roche Ireland Limited, Roche Kazakhstan LLP, Roche Kenya Limited, Roche Korea Company Ltd., Roche Laboratories Inc., Roche Latvija SIA, Roche Lebanon S.A.R.L., Roche Long Term Foundation, Roche Makedonija DOOEL, Roche Molecular Systems Inc., Roche Myanmar Company Limited, Roche Müstahzarlari Sanayi Anonim Sirketi, Roche Nederland B.V., Roche NimbleGen, Roche Norge A/S, Roche Operations Ltd., Roche Oy, Roche PVT GmbH, Roche Pakistan Limited, Roche Palo Alto LLC, Roche Pars Co. (Ltd.), Roche Pharma (Switzerland) Ltd, Roche Pharma AG, Roche Pharmaceuticals (Israel) Ltd., Roche Pharmaceuticals Middle East FZCO, Roche Pharmholding B.V., Roche Polska Sp. z o.o., Roche Privacy GmbH, Roche Products (India) Private Limited, Roche Products (Ireland) Limited, Roche Products (Mauritius) Ltd, Roche Products (New Zealand) Limited, Roche Products (Proprietary) Limited, Roche Products Ghana Limited, Roche Products Inc., Roche Products Limited, Roche Products Ltd., Roche Products Pty. Limited, Roche Products Saudi Arabia LLC, Roche R&D Center (China) Ltd., Roche Real Estate Services Mannheim GmbH, Roche Registration GmbH, Roche Registration Limited, Roche Romania S.R.L., Roche S.A., Roche S.p.A., Roche SAS, Roche Sequencing Solutions Inc., Roche Services (Asia Pacific) Sdn. Bhd., Roche Services (Europe) Ltd, Roche Services Americas Sociedad de Responsabilidad Limitada, Roche Services Holdings Ltd., Roche Servicios S.A., Roche Servicios de México S.A. de C.V., Roche Singapore Pte. Ltd., Roche Singapore Technical Operations Pte. Ltd., Roche Sistemas de Diagnósticos Sociedade Unipessoal Lda., Roche Slovensko S.R.O., Roche TCRC Inc., Roche Thailand Limited, Roche Tunisie SA, Roche Ukraine LLC, Roche Vietnam Company Limited, Roche a/s Medicinalvarer og Kemikalier, Roche d.o.o., Roche d.o.o. farmaceutsko drustvo – Roche Ltd. Pharmaceutical Company, Roche farmacevtska družba d.o.o., Roche mtm laboratories AG, Roche s.r.o., Santaris Pharma, Sapac Corporation Ltd., Seragon Pharmaceuticals Inc., Shanghai Roche Pharmaceuticals Limited, Signature Diagnostics GmbH, Spark Therapeutics, Spring Bioscience Corp., Stratos Genomics, Syntex Corporation, Syntex Pharm AG, Syntex Pharmaceuticals International Limited, Syntex Puerto Rico Inc., Tanox Inc., Tavero AG, Tensha Therapeutics, Tensha Therapeutics Inc., Therapeutic Human Polyclonals, Therapeutic Human Polyclonals Inc., Trophos, Trophos SA, Tusk Therapeutics, Tusk Therapeutics Limited, UAB Roche Lietuva, Ventana Medical Systems, Ventana Medical Systems Inc., Verum Diagnostica GmbH, Viewics, Viewics Inc., Viewics India Private Limited, mySugr, mySugr GmbH, and mySugr Inc..
Read More
This page (OTCMKTS:RHHBY) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners